Contact Us

Serine 970 of RNA helicase MOV10 is phosphorylated and controls unfolding activity and fate of mRNAs targeted for AGO2-mediated silencing.

  • Published April 3, 2023
  • by Eclipsebio

Share

Intro text lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Related articles

Sponsorships

02
24
25

Decoding Microproteins Across Evolution and Disease

Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.

read more
RNA molecules floating over a blue background

eBlogs

02
19
25

mRNA therapeutics – a new era in replacing traditional treatments

mRNA therapeutics are fundamentally transforming the way we approach modern medicine. In this eBlog we review how mRNA is providing rapid and scalable solutions.

read more
Person typing on a keyboard with bioinformatics images overlaid

eBlogs

01
14
25

AI-driven RNA drug development: a new era of discovery

Artificial intelligence is revolutionizing drug development, yet several challenges remain. In this eBlog we review the impact of AI-powered drug design for RNA-based and RNA-targeting therapies.

read more
Sign saying Review 2024

eBlogs

12
13
24

A look back at 2024: exciting advancements in RNA 

In this end-of-year eBlog, our team reflects on the successes of RNA research and drug development in 2024.

read more